MarketLine Industry Profile Global Biotechnology February 2015 Reference Code: 0199-0695 Publication Date: February 2015 WWW.MARKETLINE.COM MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Global - Biotechnology © MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED 0199 - 0695 - 2014 Page | 1 EXECUTIVE SUMMARY Market value The global biotechnology industry grew by 4.7% in 2014 to reach a value of $323.1 billion. Market value forecast In 2019
Premium Biotechnology
House of Commons Environmental Audit Committee Are biofuels sustainable? First Report of Session 2007–08 Volume I HC 76-I House of Commons Environmental Audit Committee Are biofuels sustainable? First Report of Session 2007–08 Volume I Report‚ together with formal minutes Ordered by The House of Commons to be printed 15 January 2008 HC 76-I Published on 21 January 2008 by authority of the House of Commons London: The Stationery Office Limited £11.00 The Environmental Audit
Premium Biofuel Carbon dioxide Greenhouse gas
2011 AN N UA L RE PO R T For the year ended March 31 CONTENTS 27 To Know Us Better 2 Meiji Group 2020 Vision Concept 4 Financial Highlights (Consolidated) 28 Research and Development 6 To Our Shareholders and Customers 30 Meiji Group Overseas Network 8 Interview with the President 32 Meiji Group’s Approach to CSR 12 Special Feature: Growth Strategies in Our “2020 Vision” 34 Corporate Governance and Internal Control 18 Overall
Premium Milk Fiscal year Revenue
articles The value of the world’s ecosystem services and natural capital Robert Costanza*†‚ Ralph d’Arge‡‚ Rudolf de Groot§‚ Stephen Farberk‚ Monica Grasso†‚ Bruce Hannon¶‚ Karin Limburg#✩‚ Shahid Naeem**‚ Robert V. O’Neill††‚ Jose Paruelo‡‡‚ Robert G. Raskin§§‚ Paul Suttonkk & Marjan van den Belt¶¶ * Center for Environmental and Estuarine Studies‚ Zoology Department‚ and † Insitute for Ecological Economics‚ University of Maryland‚ Box 38‚ Solomons‚ Maryland 20688‚ USA ‡ Economics Department
Premium Ecosystem Ecology
Executive Summary Biogen is a global biotechnology company headquartered in Cambridge‚ Massachusetts. Biogen is engaged in the research and development of biopharmaceuticals for human health care. Its main product is Avonex‚ a drug for the treatment of Multiple Sclerosis. Eighty-two percent of its revenues in 2000 came from the sale of this sole product. Biogen is also involved in the research of drugs for psoriasis‚ Crohn ’s disease‚ congestive heart failure‚ and cancer. Biogen believes
Premium Pharmaceutical industry Drug discovery Biotechnology
Genomic-Based High Throughput Screening Identifies Small Molecules That Differentially Inhibit the Antiviral and Immunomodulatory Effects of IFN-α Bo Chen‚1* Qin Zong‚2* Ricardo Cibotti‚1* Chad Morris‚1 Juana Castaneda‚2 Brian Naiman‚1 Derong Liu‚2 Anna Glodek‚2 Gary P Sims‚1 Ronald Herbst‚1 Stephen K Horrigan‚2 Peter A Kiener‚1 Dan Soppet‚2 Anthony J Coyle‚1 and Laurent Audoly1 1 Respiratory‚ Inflammation and Autoimmunity Department‚ MedImmune Inc.‚ Gaithersburg‚ Maryland‚ United States
Premium Gene expression Systemic lupus erythematosus
phosphorus from a shallow eutrophic lake. Hydrobiologia 299: 89-94. COVICH‚ A.P.‚ PALMER‚ A.M. and CROWL‚ T.A. 1999. The role of BenthicMacroinvertebrate species in freshwater systems: Zoobenthic species influence in energy flows and nutrient cycling. BioScience 49 (2): 119-127 DALLAS‚ H.F DUDGEON‚ D.‚ ARTHINGTON‚ A.H. and GESSNER‚ M.O. 2006. Freshwater biodiversity: importance‚ threats‚ status and conservation challenges. Biological Reviews‚ 81‚ 163–182. FLORES‚ M. J. and ZAFARALLA‚ M. 2012. Macroinvertebrate
Premium Water Water supply Insect
Manuka Honey: Topical aid for skin enhancement and healing Recently while traveling in New Zealand‚ I had the opportunity to learn more about a remedy that derives from a plant native to that country. Manuka honey‚ made from the collected nectar of the plant Leptospermum scoparium‚ is a widely employed‚ well studied topical aid for a variety of wounds‚ burns‚ cuts‚ infections and other skin problems. Honey has been used for many years in beauty‚ medicine‚ and embalming‚ due to its aseptic composition
Premium Honey
com/journal/sensors Article From Lateral Flow Devices to a Novel Nano-Color Microfluidic Assay Saied Assadollahi 1‚2‚ Christiane Reininger 1‚3‚ Roland Palkovits 1‚3‚ Peter Pointl 1 and Thomas Schalkhammer 1‚2‚* 1 2 3 Attophotonics Biosciences GmbH‚ Viktor Kaplan Strasse 2‚ A-2700 Wiener Neustadt‚ Austria; E-Mails: palkovits@attophotonics.com (R.P.); Reininger@attophotonics.com(C.R.); pointl@attophotonics.com (P.P.) Max F. Perutz Laboratories‚ Department of Biochemistry and Molecular
Premium Fluid dynamics
Contents Business sector What is the main business of the group? Are there other activities‚ complementary businesses within the group? What are the main group ’s competitors? Which main risks (that are inherent to this business sector) does the company mention? Which hedging policies are put in place? Profitability Which indicators have been brought forward in the annual report of the company? Which specific targets are aimed at? How does the
Premium Balance sheet Asset